I have been highly critical of the British Medical Journal, with good reason. It publishes some good research, and way too much political tripe.
This story falls more into the former category than the latter.
The US Food and Drug Administration says that it takes conflicts of interest seriously. But financial entanglements with the drug industry are common among its leaders.
Peter Doshi reports
🔗 https://t.co/LM9hJdDo1F pic.twitter.com/HatkDZyvAM— The BMJ (@bmj_latest) May 8, 2024
Anybody who has taken a serious interest in the relationship between the Food and Drug Administration and the pharmaceutical and medical device industries is struck by an obvious fact: the revolving door between the regulators and the regulated is utterly corrupt.
The phenomenon is called regulatory capture. When this happens, as it often does, the regulators see their own interests as more aligned…
